Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk

Human Molecular Genetics

Volumn 20, Issue 11, 2011, Pages 2263-2272

  Pearce, Celeste Leigh ^a   Doherty, Jennifer A ^b   Van Den Berg, David J ^a   Moysich, Kirsten ^c   Hsu, Chris ^a   Cushing Haugen, Kara L ^b   Conti, David V ^a   Ramus, Susan J ^d   Gentry Maharaj, Aleksandra ^d   Menon, Usha ^d   Gayther, Simon A ^d   Pharoah, Paul D P ^e   Song, Honglin ^e   Kjaer, Susanne K ^f,g   Hogdall, Estrid ^f   Hogdall, Claus ^g   Whittemore, Alice S ^h   McGuire, Valerie ^h   Sieh, Weiva ^h   Gronwald, Jacek ⁱ   Medrek, Krzysztof ⁱ   Jakubowska, Anna ⁱ   Lubinski, Jan ⁱ   Chenevix Trench, Georgia ^j   Beesley, Jonathan ^j   Webb, Penelope M ^j   Berchuck, Andrew ^k   Schildkraut, Joellen M ^k   Iversen, Edwin S ^l   Moorman, Patricia G ^k   Edlund, Christopher K ^a   Stram, Daniel O ^a   Pike, Malcolm C ^a   Ness, Roberta B ^m   Rossing, Mary Anne ^b   Wu, Anna H ^a   more..

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^g International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ POMERANIAN MEDICAL UNIVERSITY   (Poland)

^j ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^k DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l DUKE UNIVERSITY MEDICAL CENTER   (United States)

^m UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ALLELE; ARTICLE; CANCER INVASION; CANCER RISK; CONTROLLED STUDY; EPITHELIUM TUMOR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 79955993932     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr087     Document Type: Article

References (44)

1. Auranen, A., Pukkala, E., Makinen, J., Sankila, R., Grenman, S. and Salmi, T. (1996) Cancer incidence in the first-degree relatives of ovarian cancer patients. Br. J. Cancer, 74, 280-284.
2. Lichtenstein, P., Holm, N.V., Verkasalo, P.K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A. and Hemminki, K. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 343, 78-85.
3. Antoniou, A.C. and Easton, D.F. (2006) Risk prediction models for familial breast cancer. Future Oncol., 2, 257-274.
4. Schildkraut, J.M., Goode, E.L., Clyde, M.A., Iversen, E.S., Moorman, P.G., Berchuck, A., Marks, J.R., Lissowska, J., Brinton, L., Peplonska, B. et al. (2009) Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res., 69, 2349-2357.
5. Song, H., Ramus, S.J., Kjaer, S.K., DiCioccio, R.A., Chenevix-Trench, G., Pearce, C.L., Hogdall, E., Whittemore, A.S., McGuire, V., Hogdall, C. et al. (2009) Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum. Mol. Genet., 18, 2297-2304.
6. Doherty, J.A., Rossing, M.A., Cushing-Haugen, K.L., Chen, C., Van Den Berg, D.J., Wu, A.H., Pike, M.C., Ness, R.B., Moysich, K., Chenevix-Trench, G. et al. (2010) ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk, an Ovarian Cancer Association Consortium study. Cancer Epidemiol. Biomarkers Prev., 19, 245-250.
7. Song, H., Ramus, S.J., Tyrer, J., Bolton, K.L., Gentry-Maharaj, A., Wozniak, E., Anton-Culver, H., Chang-Claude, J., Cramer, D.W., DiCioccio, R. et al. (2009) A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat. Genet., 41, 996- 1000.
8. Goode, E.L., Chenevix-Trench, G., Song, H., Ramus, S.J., Notaridou, M., Lawrenson, K., Widschwendter, M., Vierkant, R.A., Larson, M.C., Kjaer, S.K. et al. (2010) A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat. Genet., 42, 874-879.
9. Bolton, K.L., Tyrer, J., Song, H., Ramus, S.J., Notaridou, M., Jones, C., Sher, T., Gentry-Maharaj, A., Wozniak, E., Tsai, Y.Y. et al. (2010) Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat. Genet., 42, 880-884.
10. Pollak, M. (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer, 8, 915-928.
11. Yee, D., Morales, F.R., Hamilton, T.C. and Von Hoff, D.D. (1991) Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer. Cancer Res., 51, 5107-5112.
12. Brokaw, J., Katsaros, D., Wiley, A., Lu, L., Su, D., Sochirca, O., de la Longrais, I.A., Mayne, S., Risch, H. and Yu, H. (2007) IGF-I in epithelial ovarian cancer and its role in disease progression. Growth Factors, 25, 346-354.
13. Spentzos, D., Cannistra, S.A., Grall, F., Levine, D.A., Pillay, K., Libermann, T.A. and Mantzoros, C.S. (2007) IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer. Endocr. Relat. Cancer, 14, 781-790.
14. Lukanova, A., Lundin, E., Toniolo, P., Micheli, A., Akhmedkhanov, A., Rinaldi, S., Muti, P., Lenner, P., Biessy, C., Krogh, V. et al. (2002) Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int. J. Cancer, 101, 549-554.
15. Peeters, P.H., Lukanova, A., Allen, N., Berrino, F., Key, T., Dossus, L., Rinaldi, S., van Gils, C.H., Bueno-de-Mesquita, H.B., Boeing, H. et al. (2007) Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk, the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr. Relat. Cancer, 14, 81-90.
16. Tworoger, S.S., Lee, I.M., Buring, J.E., Pollak, M.N. and Hankinson, S.E. (2007) Insulin-like growth factors and ovarian cancer risk, a nested case- control study in three cohorts. Cancer Epidemiol. Biomarkers Prev., 16, 1691-1695.
17. Berchuck, A., Iversen, E.S., Lancaster, J.M., Pittman, J., Luo, J., Lee, P., Murphy, S., Dressman, H.K., Febbo, P.G., West, M. et al. (2005) Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin. Cancer Res., 11, 3686-3696.
18. Kim, H.T., Choi, B.H., Niikawa, N., Lee, T.S. and Chang, S.I. (1998) Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors. Am. J. Med. Genet., 80, 391-395.
19. Murphy, S.K., Huang, Z., Wen, Y., Spillman, M.A., Whitaker, R.S., Simel, L.R., Nichols, T.D., Marks, J.R. and Berchuck, A. (2006) Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer. Mol. Cancer Res., 4, 283-292.
20. Sawiris, G.P., Sherman-Baust, C.A., Becker, K.G., Cheadle, C., Teichberg, D. and Morin, P.J. (2002) Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer. Cancer Res., 62, 2923-2928.
21. Sayer, R.A., Lancaster, J.M., Pittman, J., Gray, J., Whitaker, R., Marks, J.R. and Berchuck, A. (2005) High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer. Gynecol. Oncol., 96, 355-361.
22. Yun, K., Fukumoto, M. and Jinno, Y. (1996) Monoallelic expression of the insulin-like growth factor-2 gene in ovarian cancer. Am. J. Pathol., 148, 1081-1087.
23. Launonen, V., Mannermaa, A., Stenback, F., Kosma, V.M., Puistola, U., Huusko, P., Anttila, M., Bloigu, R., Saarikoski, S., Kauppila, A. and Winqvist, R. (2000) Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer, correlation to clinicopathological variables. Cancer Genet. Cytogenet., 122, 49-54.
24. Beauchamp, M.C., Yasmeen, A., Knafo, A. and Gotlieb, W.H. (2010) Targeting insulin and insulin-like growth factor pathways in epithelial ovarian cancer. J. Oncol., 2010, 257058.
25. Terry, K.L., Tworoger, S.S., Gates, M.A., Cramer, D.W. and Hankinson, S.E. (2009) Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk. Carcinogenesis, 30, 2042-2046.
26. Giudice, L.C. IGFs in the female reproductive system. In Rosenfeld, R.G. and Roberts, C.T. (eds), The IGF System. Humana Press, Inc., New Jersey, 1999, 379-405.
27. Ohlsson, R. (2004) Loss of IGF2 imprinting, mechanisms and consequences. Novartis Found Symp., 262, 108-121; discussion 121-104, 265-108.
28. Zheng, J., Wan, M., Zweizig, S., Velicescu, M., Yu, M.C. and Dubeau, L. (1993) Histologically benign or low-grade malignant tumors adjacent to high-grade ovarian carcinomas contain molecular characteristics of high-grade carcinomas. Cancer Res., 53, 4138-4142.
29. Lu, K.H., Weitzel, J.N., Kodali, S., Welch, W.R., Berkowitz, R.S. and Mok, S.C. (1997) A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas. Cancer Res., 57, 387-390.
30. Mor, G., Visintin, I., Lai, Y., Zhao, H., Schwartz, P., Rutherford, T., Yue, L., Bray-Ward, P. and Ward, D.C. (2005) Serum protein markers for early detection of ovarian cancer. Proc. Natl Acad. Sci. USA, 102, 7677-7682.
31. Visintin, I., Feng, Z., Longton, G., Ward, D.C., Alvero, A.B., Lai, Y., Tenthorey, J., Leiser, A., Flores-Saaib, R., Yu, H. et al. (2008) Diagnostic markers for early detection of ovarian cancer. Clin. Cancer Res., 14, 1065-1072.
32. Rossing, M.A., Cushing-Haugen, K.L., Wicklund, K.G., Doherty, J.A. and Weiss, N.S. (2007) Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol. Biomarkers Prev., 16, 2548-2556.
33. Ness, R.B., Shen, C., Bass, D., Jackson, C., Moysich, K., Edwards, R. and Brunham, R.C. (2008) Chlamydia trachomatis serology in women with and without ovarian cancer. Infect. Dis. Obstet. Gynecol., 2008, 219672.
34. Pike, M.C., Pearce, C.L., Peters, R., Cozen, W., Wan, P. and Wu, A.H. (2004) Hormonal factors and the risk of invasive ovarian cancer, a population-based case-control study. Fertil. Steril., 82, 186-195.
35. Wu, A.H., Pearce, C.L., Tseng, C.C., Templeman, C. and Pike, M.C. (2009) Markers of inflammation and risk of ovarian cancer in Los Angeles County. Int. J. Cancer, 124, 1409-1415.
36. Beesley, J., Jordan, S.J., Spurdle, A.B., Song, H., Ramus, S.J., Kjaer, S.K., Hogdall, E., DiCioccio, R.A., McGuire, V., Whittemore, A.S. et al. (2007) Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer, results from two Australian studies and an additional validation set. Cancer Epidemiol. Biomarkers Prev., 16, 2557-2565.
37. Kjaerbye-Thygesen, A., Frederiksen, K., Hogdall, E.V., Glud, E., Christensen, L., Hogdall, C.K., Blaakaer, J. and Kjaer, S.K. (2006) Smoking and overweight, negative prognostic factors in stage III epithelial ovarian cancer. Cancer Epidemiol. Biomarkers Prev., 15, 798-803.
38. Song, H., Ramus, S.J., Quaye, L., DiCioccio, R.A., Tyrer, J., Lomas, E., Shadforth, D., Hogdall, E., Hogdall, C., McGuire, V. et al. (2006) Common variants in mismatch repair genes and risk of invasive ovarian cancer. Carcinogenesis, 27, 2235-2242.
39. Ramus, S.J., Vierkant, R.A., Johnatty, S.E., Pike, M.C., Van Den Berg, D.J., Wu, A.H., Pearce, C.L., Menon, U., Gentry-Maharaj, A., Gayther, S.A. et al. (2008) Consortium analysis of 7 candidate SNPs for ovarian cancer. Int. J. Cancer, 123, 380-388.
40. Menon, U., Gentry-Maharaj, A., Hallett, R., Ryan, A., Burnell, M., Sharma, A., Lewis, S., Davies, S., Philpott, S., Lopes, A. et al. (2009) Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers, results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol., 10, 327-340.
41. McGuire, V., Felberg, A., Mills, M., Ostrow, K.L., DiCioccio, R., John, E.M., West, D.W. and Whittemore, A.S. (2004) Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations. Am. J. Epidemiol., 160, 613-618.
42. Schildkraut, J.M., Moorman, P.G., Bland, A.E., Halabi, S., Calingaert, B., Whitaker, R., Lee, P.S., Elkins-Williams, T., Bentley, R.C., Marks, J.R. and Berchuck, A. (2008) Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup. Cancer Epidemiol. Biomarkers Prev., 17, 585-593.
43. Edlund, C.K., Lee, W.H., Li, D., Van Den Berg, D.J. and Conti, D.V. (2008) Snagger, a user-friendly program for incorporating additional information for tagSNP selection. BMC Bioinformatics, 9, 174.
44. Hunter, D.J., Riboli, E., Haiman, C.A., Albanes, D., Altshuler, D., Chanock, S.J., Haynes, R.B., Henderson, B.E., Kaaks, R., Stram, D.O. et al. (2005) A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat. Rev. Cancer, 5, 977-985.